Distraction and Nitrous Oxide for Venous Puncture

NCT ID: NCT04185233

Last Updated: 2021-01-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-04-30

Study Completion Date

2020-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will compare the efficiency of the iPad distraction or the administration of Nitrous Oxide on the anxiety decrease when a peripheral venous catheter is needed in children between 3 and 9 years old.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is aiming at demonstrating the efficacy of active distraction by an iPad on the anxiety consequent to venipuncture and insertion of a peripheral vein catheter. The comparator is nitrous oxide in a 50% mixture with oxygen that is routinely used for sedation during procedural pain. However, nitrous oxide has secondary effects particularly on the inhibition of Vitamin B12.

The primary outcome is anxiety scores. Secondary outcomes are pain scores and satisfaction of parents and health providers.

All children will have EMLA cream (mixture prilocaine and lidocaine) applied one hour prior to venous punction. Anxiety, pain and satisfaction scores will be recorded at baseline and then within an hour following the venipuncture and insertion of the peripheral vein catheter.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Pain Venous Puncture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized clinical trial
Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

iPad distraction

Children of this group will receive the iPad when the nurse will prepare the material for the venous track. They will choose a game adapted to their age and will be able to play it during all the procedure time.

Intervention : game on iPad

Group Type EXPERIMENTAL

Games on an iPad

Intervention Type OTHER

Many games will be programmed on the iPad and organized by age. The child will choose one game and play it during all the procedure time.

Nitrous Oxide

Children of this group will receive the Nitrous Oxide 3 minutes before the intervention (venous track). They will keep the mask during all the procedure time.

Intervention : Nitrous Oxide

Group Type ACTIVE_COMPARATOR

Nitrous Oxide

Intervention Type DRUG

Nitrous oxide will be provided to the child by a mask 3 minutes before the intervention and during all this one.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Games on an iPad

Many games will be programmed on the iPad and organized by age. The child will choose one game and play it during all the procedure time.

Intervention Type OTHER

Nitrous Oxide

Nitrous oxide will be provided to the child by a mask 3 minutes before the intervention and during all this one.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Venous track needed
* French mother tongue
* Age between 3 and 9 years old

Exclusion Criteria

* Children with cognitive disorder (autism, metabolic disorders,
* Children with cerebral-motor disability
* Children who don't speak french
* Children with ADHD treatment
* Children with epilepsy
* Children who present contraindication to the use of Nitrous oxide
Minimum Eligible Age

3 Years

Maximum Eligible Age

9 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Geneva

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Walid HABRE

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Manon Cadoux, Student

Role: PRINCIPAL_INVESTIGATOR

University of Geneva

Virginie Luscher, Student

Role: PRINCIPAL_INVESTIGATOR

University of Geneva

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Geneva Children's Hospital

Geneva, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

in progress

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Nitrous Oxide for Lumbar Puncture
NCT03228628 UNKNOWN PHASE4